Abstract| Volume 13, ISSUE 10, SUPPLEMENT , S195, October 2017

Short-Term Results For Intermittent Vagal Nerve Blocking (vBloc) In The “Real-World”, Nonresearch Environment

      Clinical trials often analyze and report outcomes from ideal settings where sites and investigators are deliberately selected, and patients have met stringent requirements to participate. These outcomes may not be seen in clinical settings. We report the initial “real-world” experience with vBloc therapy in a cohort of patients with severe obesity in 14 centers across the U.S., including surgeries performed at a VA hospital.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Surgery for Obesity and Related Diseases
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect